Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Accrued Liabilities and other Long-Term Liabilities

12 Months Ended

Dec. 31, 2018

10. Accrued Liabilities and other Long-Term Liabilities

Accrued expenses and other long-term liabilities, excluding National, consisted of the following:

	December 31,
($ in thousands)	2018		2017
Accrued expenses:
Professional fees	$	1,434	$	1,625
Salaries, bonuses and related benefits		5,843		5,279
Accrued expenses - related party		-		95
Research and development		3,805		1,873
Research and development - milestones		200		800
Research and development - manufacturing		826		1,188
Research and development - clinical supplies		160		85
Research and development - license maintenance fees		519		100
Dr. Falk Pharma settlement		300		3,059
Accrued royalties payable		1,108		1,411
Accrued coupon expense		838		1,087
Other		1,327		1,030
Total accrued expenses	$	16,360	$	17,632

Other long-term liabilities:
Deferred rent and long-term lease abandonment charge		5,211		4,739
Total other long-term liabilities	$	5,211	$	4,739